• Fig 3 Atlas of concordant results between DHPLC and direct sequencing. The arrows indicated the mutant peaks.

    图3DHPLC与直接测序结果相符的检测图谱,箭头提示突变峰。

    youdao

  • Screening the mutations and polymorphisms by denaturing high-performance liquid chromatography(DHPLC) and DNA sequencing Results: 1.

    应用变性高效液相色谱(DHPLC)分析及直接基因测序筛查突变和多态。

    youdao

  • CONCLUSION: We first amplified mtDNA in circulating plasma from breast cancer patients by direct PCR, checked mutation by DHPLC and confirmed results by sequencing.

    结论:本实验直接用PCR扩增乳腺癌血浆核酸中线粒体基因,并用DHPLC初步筛选突变并测序证实。

    youdao

  • Objective to detect the ABL point mutations in chronic myeloid leukemia (CML) patients treated with imatinib by denaturing high-performance liquid chromatography (DHPLC).

    目的应用变性高效液相色谱(DHPLC)检测伊马替尼治疗后慢性髓性白血病(CML)患者ABL激酶区点突变。

    youdao

  • Objective to detect the ABL point mutations in chronic myeloid leukemia (CML) patients treated with imatinib by denaturing high-performance liquid chromatography (DHPLC).

    目的应用变性高效液相色谱(DHPLC)检测伊马替尼治疗后慢性髓性白血病(CML)患者ABL激酶区点突变。

    youdao

$firstVoiceSent
- 来自原声例句
小调查
请问您想要如何调整此模块?

感谢您的反馈,我们会尽快进行适当修改!
进来说说原因吧 确定
小调查
请问您想要如何调整此模块?

感谢您的反馈,我们会尽快进行适当修改!
进来说说原因吧 确定